I'm not sure I get why this is such a big deal π€...back in the day, like 10 years ago, Novo Nordisk was already doing alright for themselves with Ozempic, and now they're trying to muscle in on Pfizer's turf? I mean, I guess it's good for Metsera that they're getting some serious investment, but...